Cord Blood Banking Services Market Report by Component, Storage Services, Application, and Region 2024-2032
세계의 제대혈 은행 서비스 시장 규모는 2023년 18억 달러에 달했습니다. IMARC Group은 2024년부터 2032년까지의 복합 연간 성장률(CAGR)은 9.5%로 2032년에는 42억 달러에 달할 것으로 예측했습니다.
제대혈 은행은 제대와 태반에서 구명 줄기 세포를 채취하고 향후 사용을 위해 저장하는 절차입니다. 아기의 제대혈에 포함된 조혈 줄기세포를 사용하여 적혈구(RBC), 백혈구(WBC), 혈소판으로 성장시킵니다. 제대혈 은행은 골수에서 줄기 세포를 채취하는 것에 비해 기증자에게 복잡하고 고통과 위험이 적기 때문에 암이나 혈액 질환, 면역계 질환의 치료에 도움이 됩니다. 그 결과, 제대혈 은행은 병원, 연구 기관, 전문 클리닉 등에서 폭넓게 이용되고 있습니다.
제대혈 은행 서비스 시장 동향 :
장시간 노동, 스트레스가 많은 생활, 과도한 흡연이나 음주 등으로 인해 림프종과 백혈병 등 다양한 암의 유병률이 높아지고 있다는 것이 시장을 견인하는 주요 요인 중 하나입니다. 또한, 면역결핍 장애의 치료를 위해 제대혈 은행 서비스를 이용하는 경우도 세계의적으로 증가하고 있습니다. 이것은 제대혈 은행 서비스 제공업체의 장점과 광범위한 가용성에 대한 개인의 의식이 증가함에 따라 시장 성장을 가속합니다. 또한 각국 정부는 제대혈 줄기세포의 임상시험을 촉진하기 위해 연구개발(R&D) 활동에 적극적으로 투자하고 있습니다. 이에 따라 세계의 골수에 손상을 입은 환자의 수가 증가하고 있는 것도 시장에 긍정적인 영향을 미칩니다. 이 외에도 규제 당국의 지침 및 규제에 따라 민간 센터에서 제대혈 진단 스크리닝이 증가하여 업계 투자자에게 유리한 성장 기회를 제공합니다. 또한 건강 관리 산업의 확대는 시장 성장을 강화하고 있습니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사의 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 제대혈 뱅크 서비스 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 분석 : 컴포넌트별
제7장 시장 분석: 스토리지 서비스
제8장 시장 분석 : 용도별
- 암 질환
- 당뇨병
- 혈액 질환
- 면역 질환
- 대사 장애
- 기타
제9장 시장 분석 : 지역별
- 북미
- 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 라틴아메리카
- 중동 및 아프리카
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
- 개요
- 구매자의 협상력
- 공급기업의 협상력
- 경쟁도
- 신규 참가업체의 위협
- 대체품의 위협
제13장 가격 분석
제14장 경쟁 구도
- 시장 구조
- 주요 기업
- 주요 기업 프로파일
- Alphacord LLC
- Americord Registry LLC
- ATCC
- California Cryobank
- Cordlife Group LImited
- Cryo-Cell International Inc.
- Global Cord Blood Corporation
- LifeBank
- LifeCell International Pvt. Ltd.
- National Cord Blood Program
- Norton Healthcare Inc.
- Perkinelmer Inc.
- StemCyte India Therapeutics Pvt. Ltd.
BJH
The global cord blood banking services market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.2 Billion by 2032, exhibiting a growth rate (CAGR) of 9.5% during 2024-2032.
Cord blood banking is a procedure of collecting and storing life-saving stem cells from the umbilical cord and placenta for future use. It uses hematopoietic stem cells that are present in the cord blood of the baby to develop it into red blood cells (RBCs), white blood cells (WBCs) and platelets. It aids in the treatment of cancer, blood diseases and immune system disorders as cord blood banking is less complicated, painful and risky for the donor compared to the collection of stem cells from bone marrow. As a result, it finds extensive applications in hospitals, research institutes, and specialty clinics.
Cord Blood Banking Services Market Trends:
The growing prevalence of different cancers, such as lymphoma and leukemia, due to longer working hours, stressful lives, and excessive smoking and alcohol consumption represents one of the key factors driving the market. Moreover, there is an increase in the utilization of cord blood banking services for the treatment of immunodeficiency disorders across the globe. This, coupled with the increasing awareness among individuals about the benefits and wide availability of cord blood banking service providers, is propelling the growth of the market. In addition, governments of several countries are extensively investing in research and development (R&D) activities to facilitate clinical trials of cord blood stem cells. In line with this, the growing number of patients with damaged bone marrow worldwide is positively influencing the market. Besides this, the rising diagnostic screening of cord blood in private centers as per guidelines and regulations of regulatory authorities is offering lucrative growth opportunities to industry investors. Additionally, the expanding healthcare industry is strengthening the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cord blood banking services market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on component, storage services and application.
Breakup by Component:
Cord Blood
Cord Tissue
Breakup by Storage Services:
Public Cord Blood Banks
Private Cord Blood Banks
Breakup by Application:
Cancer Disease
Diabetes
Blood Disease
Immune Disorders
Metabolic Disorders
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Alphacord LLC, Americord Registry LLC, ATCC, California Cryobank, Cordlife Group LImited, Cryo-Cell International Inc., Global Cord Blood Corporation, LifeBank, LifeCell International Pvt. Ltd., National Cord Blood Program, Norton Healthcare Inc., Perkinelmer Inc. and StemCyte India Therapeutics Pvt. Ltd.
Key Questions Answered in This Report:
- How has the global cord blood banking services market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global cord blood banking services market?
- What are the key regional markets?
- What is the breakup of the market based on the component?
- What is the breakup of the market based on the storage services?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global cord blood banking services market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Cord Blood Banking Services Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Component
- 6.1 Cord Blood
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Cord Tissue
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Storage Services
- 7.1 Public Cord Blood Banks
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Private Cord Blood Banks
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Application
- 8.1 Cancer Disease
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Diabetes
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Blood Disease
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Immune Disorders
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Metabolic Disorders
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Alphacord LLC
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Americord Registry LLC
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 ATCC
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 California Cryobank
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Cordlife Group LImited
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.6 Cryo-Cell International Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.7 Global Cord Blood Corporation
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 LifeBank
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 LifeCell International Pvt. Ltd.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 National Cord Blood Program
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 Norton Healthcare Inc.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.12 Perkinelmer Inc.
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis
- 14.3.13 StemCyte India Therapeutics Pvt. Ltd.
- 14.3.13.1 Company Overview
- 14.3.13.2 Product Portfolio
